U2Bio Co., Ltd. (KOSDAQ:221800)
South Korea
· Delayed Price · Currency is KRW 19,490
-910 (-4.46%)
At close: Apr 28, 2026
U2Bio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2014 | 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '14 Dec 31, 2014 | 2013 |
| Market Capitalization | 310,524 | 53,093 | 30,080 | 59,596 | 49,318 | - | Upgrade
|
| Market Cap Growth | 743.90% | 76.50% | -49.53% | 20.84% | - | - | Upgrade
|
| Enterprise Value | 279,200 | 23,146 | -3,866 | 23,197 | 52,691 | - | Upgrade
|
| Last Close Price | 19490.00 | 3920.00 | 2596.84 | 5144.96 | 6286.26 | - | Upgrade
|
| PE Ratio | - | - | - | 92.27 | 3.75 | - | Upgrade
|
| PS Ratio | 12.13 | 2.08 | 1.20 | 1.94 | 0.72 | - | Upgrade
|
| PB Ratio | 7.34 | 1.25 | 0.87 | 1.57 | 1.46 | - | Upgrade
|
| P/TBV Ratio | 7.42 | 1.27 | 0.88 | 1.58 | 1.47 | - | Upgrade
|
| P/FCF Ratio | - | - | - | - | 2.10 | - | Upgrade
|
| P/OCF Ratio | - | - | - | - | 2.02 | - | Upgrade
|
| EV/Sales Ratio | 10.91 | 0.90 | - | 0.75 | 0.76 | - | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | 3.18 | - | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 3.35 | - | Upgrade
|
| EV/FCF Ratio | -168.81 | - | - | - | 2.25 | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 1.13 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | 0.03 | 4.77 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 0.02 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.74 | -0.74 | -0.97 | -0.96 | -1.08 | 0.87 | Upgrade
|
| Net Debt / EBITDA Ratio | 23.08 | 23.08 | 16.35 | 86.70 | -2.19 | 3.68 | Upgrade
|
| Net Debt / FCF Ratio | 18.94 | 18.94 | 18.90 | 13.12 | -1.55 | -2.28 | Upgrade
|
| Asset Turnover | 0.53 | 0.53 | 0.53 | 0.61 | - | 1.06 | Upgrade
|
| Inventory Turnover | 27.56 | 27.56 | 26.49 | 30.54 | - | 18.23 | Upgrade
|
| Quick Ratio | 6.24 | 6.24 | 6.27 | 5.52 | 3.22 | 1.79 | Upgrade
|
| Current Ratio | 6.39 | 6.39 | 6.40 | 5.64 | 3.27 | 1.88 | Upgrade
|
| Return on Equity (ROE) | -4.28% | -4.28% | -7.85% | 1.80% | - | 9.93% | Upgrade
|
| Return on Assets (ROA) | -2.81% | -2.81% | -3.89% | -1.67% | - | 4.15% | Upgrade
|
| Return on Invested Capital (ROIC) | -29.99% | -36.92% | -229.92% | - | 547.93% | 11.16% | Upgrade
|
| Return on Capital Employed (ROCE) | -4.80% | -4.80% | -7.60% | -3.20% | 43.20% | 11.10% | Upgrade
|
| Earnings Yield | -0.53% | -3.09% | -9.44% | 1.08% | 26.68% | - | Upgrade
|
| FCF Yield | -0.53% | -3.12% | -5.90% | -4.65% | 47.53% | - | Upgrade
|
| Payout Ratio | - | - | - | 195.50% | 5.76% | - | Upgrade
|
| Buyback Yield / Dilution | -3.32% | -3.32% | -9.26% | -2.14% | -598.90% | -22.57% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.